Initial Therapeutics

Initial Therapeutics, Inc. is a preclinical-stage biotechnology company in South San Francisco, California, discovering and developing a new class of small-molecule medicines designed to halt pathogenic protein formation in its earliest stages. Its proprietary STOPS platform — Selective Termination of Protein Synthesis — intercepts the translation of a target protein inside the exit tunnel of the ribosome, recognizing the nascent primary linear sequence rather than a fully folded three-dimensional structure, an approach the company positions as starkly differentiated from targeted protein degradation and from interventions that can only act on proteins after they are fully formed. The company launched publicly on May 1, 2023 with a $75 million Series A from Apple Tree Partners, was co-founded with academic scientists Jamie H. D. Cate (UC Berkeley), Brian Paegel (UC Irvine) and Kevan Shokat (UCSF/UC Berkeley), and builds on ribosome biochemistry, proteomics, medicinal chemistry, DNA-encoded library technology and chemical genetics, with early programs aimed at oncology targets long considered undruggable. Initial Therapeutics is a therapeutics discovery company, not a software vendor: it publishes a small marketing website and no public API, SDK, developer portal or machine-readable contract of any kind.

Initial Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Therapeutics, Drug Discovery, and Small Molecules.

🌐 Visit website 📡 Source on GitHub

2.9/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-25 · rubric v0.14.0

0 APIs

Company Biotechnology Therapeutics Drug Discovery Small Molecules Oncology Life Sciences Preclinical

Kin Score

Kin Score How this is scored →
scored 2026-08-25 · rubric v0.14.0

Composite quality — 2.9/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 0.0 / 17

Access Clarity 0.0 / 17

Operational Transparency 0.0 / 11

Contract Governance 0.0 / 10

Discoverability 3.9 / 9

Regulatory Posture 1.1 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

Documented Reversibility 0 / 6

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Delegated User Identity 0 / 6

Protected Resource Metadata 0 / 5

Registration Without a Human 0 / 6

Agentic Commerce Surface 0 / 5

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/initial-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

LLMsTxt

LLMsTxt

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Commercial 2

Pricing, plans, and the legal terms of use

TermsOfService

TermsOfService

PrivacyPolicy

PrivacyPolicy

Company 1

The organization behind the API

Website

Website

Source (apis.yml)

aid: initial-therapeutics
name: Initial Therapeutics
description: 'Initial Therapeutics, Inc. is a preclinical-stage biotechnology company in South San Francisco, California,
  discovering and developing a new class of small-molecule medicines designed to halt pathogenic protein formation in its
  earliest stages. Its proprietary STOPS platform — Selective Termination of Protein Synthesis — intercepts the translation
  of a target protein inside the exit tunnel of the ribosome, recognizing the nascent primary linear sequence rather than
  a fully folded three-dimensional structure, an approach the company positions as starkly differentiated from targeted protein
  degradation and from interventions that can only act on proteins after they are fully formed. The company launched publicly
  on May 1, 2023 with a $75 million Series A from Apple Tree Partners, was co-founded with academic scientists Jamie H. D.
  Cate (UC Berkeley), Brian Paegel (UC Irvine) and Kevan Shokat (UCSF/UC Berkeley), and builds on ribosome biochemistry, proteomics,
  medicinal chemistry, DNA-encoded library technology and chemical genetics, with early programs aimed at oncology targets
  long considered undruggable. Initial Therapeutics is a therapeutics discovery company, not a software vendor: it publishes
  a small marketing website and no public API, SDK, developer portal or machine-readable contract of any kind.'
url: https://raw.githubusercontent.com/api-evangelist/initial-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-23'
modified: '2026-08-23'
tags:
- Company
- Biotechnology
- Therapeutics
- Drug Discovery
- Small Molecules
- Oncology
- Life Sciences
- Preclinical
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/initial-therapeutics-domain-security.yml
- type: Website
  url: https://initialtx.com/
- type: TermsOfService
  url: https://initialtx.com/terms-of-use.html
- type: PrivacyPolicy
  url: https://initialtx.com/privacy-policy.html
- type: LLMsTxt
  url: llms/initial-therapeutics-llms.txt
x-enrichment:
  date: '2026-08-23'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Initial Therapeutics is a preclinical small-molecule drug-discovery company whose entire web presence is a five-page
    marketing site on shared SiteGround hosting, where every contract path (/openapi.json, /graphql, /llms.txt, /.well-known/*)
    returns the identical site-wide HTTP 202 robot-challenge body that a deliberately bogus path returns, and api./docs./developer.initialtx.com
    are wildcard DNS onto SiteGround's default vhost (403, certificate CN=gvam1148.siteground.biz) — there is no API here
    to gate, to read, or to hide.
  evidence:
  - url: https://initialtx.com/openapi.json
    status: 202
  - url: https://initialtx.com/.well-known/agent-card.json
    status: 202
  - url: https://api.initialtx.com/openapi.json
    status: 403
  - url: https://pypi.org/pypi/initialtx/json
    status: 404
  checked: '2026-08-23'

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this

find_providersBrowse and filter every provider in the catalog.
get_provider_artifactsEvery artifact this provider publishes, grouped by type.
get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
get_provider_ratingPRO — composite, band, trend and facet scores.
apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
resolveTurn a domain, URL or GitHub org into the provider it belongs to.
find_cohortsEvery scored population of providers in the catalog.

All 92 tools

Call it yourself

curl for this page

This provider

curl "https://apis.io/api/v1/providers/initial-therapeutics"

All providers

curl "https://apis.io/api/v1/providers?limit=25"

Every operation they expose

curl "https://apis.io/api/v1/providers/initial-therapeutics/operations?limit=25"

How their score was established

curl "https://apis.io/api/v1/providers/initial-therapeutics/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no email required.

GitHub Google LinkedIn

A second provider on the same verified email joins the account you already have.